MedDataX Logo

A Reverification of the Berlin Definition Plateau Criteria in Golmud

NCT ID: NCT05493839

Last Updated: 2022-08-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-20

Study Completion Date

2022-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a single-center retrospective study. According to the Berlin diagnostic standard, ARDS patients admitted to the Department of severe Medicine, Golmud People's Hospital from January 2015 to june 2022 were divided into three groups: mild (142mmHg \< PaO2/ FiO2 ≤ 213 mmHg), moderate (71mmHg \< PaO2/ FiO2 ≤ 142mmHg) and severe (PaO2/ FiO2 ≤ 71 mmHg). The ICU mortality, 28-day mortality, non-ventilator time in ICU, ICU hospitalization time observed respectively.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Definition of ARDS in Qinghai Province: Verification of Berlin Definition Plateau Criteria

NCT04199650

ARDS High Altitude
UNKNOWN

Clinical Empirical Research of ARDS

NCT05922826

Invasive Mechanical Ventilation ARDS
RECRUITING

ARDS Prediction Score in Critically Ill Patients in China

NCT02174081

ARDS Septic Shock
COMPLETED

Biomarkers to Predict Acute Respiratory Distress Syndrome(ARDS) in Patients With Sepsis

NCT05914428

Sepsis
UNKNOWN

The Evaluation of NETs, Caspase-1 and Cytokines in ARDS Patients

NCT03227107

ARDS
UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ards

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Plateau Criteria

mild ： 142mmHg \< PaO2/ FiO2 ≤ 213 mmHg moderate ： 71mmHg \< PaO2/ FiO2 ≤ 142mmHg severe： PaO2/ FiO2 ≤ 71 mmHg

No interventions assigned to this group

Berlin Definition

mild ： 200mmHg \< PaO2/ FiO2 ≤ 300 mmHg moderate ： 100mmHg \< PaO2/ FiO2 ≤ 200mmHg severe： PaO2/ FiO2 ≤ 100 mmHg

No interventions assigned to this group

zhang

ARDS：PaO2/FiO2≤100mmHg ALI ：100mmHg\<PaO2/FiO2≤150mmHg

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meet the diagnostic criteria of ARDS

Exclusion Criteria

* length of stay in hospital less than 48h Data missing younger than 18 years or older than 80 years
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Southeast University, China

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chun Pan

doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhongda Hospital, Southeast University

Nanjing, Jiangsu, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ARDS in Golmud

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Impact of Inflammation Biomarkers on the Acute Respiratory Distress Syndrome (ARDS) Definition
NCT01161901 COMPLETED
Validation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study
NCT07289711 RECRUITING
Radiomics Markers to Predict Sepsis Induced Acute Respiratory Distress Syndrome
NCT04541264 UNKNOWN
Research on Risk Assessment and Early Warning Models for Adverse Clinical Outcomes in Critically Ill Patients
NCT07317817 COMPLETED
Study of Biomarkers in Patients of Sepsis Complicated With Acute Respiratory Distress Syndrome (ARDS)
NCT04552821 UNKNOWN
Epidemiology of Acute Respiratory Distress Syndrome in Chinese ICUs
NCT02490215 COMPLETED
Early Biological and Mechanical Profiling in Sepsis-Associated ARDS
NCT07281911 NOT_YET_RECRUITING
Epidemiology Research on Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) in Adult ICU in Shanghai
NCT01186874 UNKNOWN
Establish a Prospective Registration System of ARDS Patients for Improving Quality of Care
NCT04032288 COMPLETED
The Early Prediction of Sepsis in ICU
NCT05088850 UNKNOWN
Correlation Between PLA Levels and Disease Severity in Patients With Sepsis Cardiac Insufficiency
NCT06655389 RECRUITING
Functional Capacity in Survivors of COVID-19 Related ARDS
NCT04952844 UNKNOWN
Renal Resistive Index and Cardiac Output Changes During Resuscitation Predict the Occurrence of Acute Kidney Injury in Septic Shock Patients
NCT01862588 UNKNOWN
Effect of Altitude on the Evolution of Acute Respiratory Distress Syndrome
NCT02871063 COMPLETED
Study on the Correlation Between Alveolar Macrophage-derived Autophagosomes and the Severity of Lung Injury in ARDS
NCT05101694 UNKNOWN
Change of Immune Cell of ARDS Patients：an Observational Study
NCT02958748 UNKNOWN
Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU
NCT04385004 UNKNOWN
Can Novel Oxygenation Indices Guide the Diagnosis of Acute Respiratory Distress Syndrome
NCT06430619 COMPLETED
Explore Potential Plasma and BALF Immunometabolic and Lipidomic Biomarkers for Identifying ARDS Endotypes
NCT05451342 UNKNOWN
Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients
NCT04408378 UNKNOWN
Lung and Systemic Inflammation in the Critically Ill Patient
NCT01906229 TERMINATED
Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients
NCT03768752 COMPLETED
Stratification of the Acute Respiratory Distress Syndrome
NCT02288949 COMPLETED
Prediction of Acute Kidney Injury in Patients With Sepsis Using Venous Excess Ultrasound Score
NCT06176807 RECRUITING
Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS Patients
NCT04508933 WITHDRAWN